BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771102. A total of 1 filers reported holding BELLEROPHON THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $134,000 | -88.5% | 383,955 | -84.1% | 0.03% | -96.2% |
| Q3 2019 | $1,165,000 | -19.7% | 2,417,227 | 0.0% | 0.72% | +6.2% |
| Q2 2019 | $1,450,000 | -8.1% | 2,417,227 | 0.0% | 0.68% | -26.4% |
| Q1 2019 | $1,578,000 | -13.4% | 2,417,227 | +6.3% | 0.92% | -30.6% |
| Q4 2018 | $1,823,000 | -25.8% | 2,274,370 | 0.0% | 1.32% | -28.6% |
| Q3 2018 | $2,456,000 | – | 2,274,370 | – | 1.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEW MOUNTAIN VANTAGE ADVISERS, L.L.C. | 4,859,885 | $11,955,000 | 0.64% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 100,000 | $246,000 | 0.00% |
| Alyeska Investment Group, L.P. | 143,985 | $354,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 31,792 | $78,000 | 0.00% |
| Geneva Advisors, LLC | 12,500 | $31,000 | 0.00% |
| BlackRock Investment Management, LLC | 846 | $2,000 | 0.00% |
| MORGAN STANLEY | 500 | $1,000 | 0.00% |
| BlackRock Institutional Trust Company, N.A. | 28,379 | $70,000 | 0.00% |
| Walleye Trading LLC | 700 | $2,000 | 0.00% |
| LPL Financial LLC | 61,246 | $131,000 | 0.00% |